Faculty of Medicine

Academic Members

Yemliha  Yıldız

Yemliha Yıldız,  Dr.

CV
Öğretim Üyesi

Yemliha Yildiz completed his undergraduate education in the Department of Biology at Anadolu University, Faculty of Science in 2006. After he got his Master’s degree in the Department of Molecular Medicine at Istanbul University Aziz Sancar Institute of Experimental Medicine in 2008, he got his doctorate in 2015 in the same department. In 2016, Dr. Yildiz has become an assistant professor in the Department of Medical Biology at Istinye University Faculty of Medicine. Dr. Yildiz, who started studying gene cloning when he was an undergraduate, studied cancer and specifically breast cancer after his graduation and he has been still doing his investigations in these areas. As he has 7 international and 2 national published articles, Dr. Yildiz also has several oral and written presentations in both national and international congresses. He worked as a Vice Principal of Vocational School of Health Services at Istinye University between 2016 – 2017. Dr. Yildiz has been the Principal of Istinye University Vocational School of Health Services since 2017.

Research Areas: Cancer Biology, Breast Cancer, Molecular Biology

Main Areas: Tıbbi Biyoloji, 

2018 - Investigation Of Nitric Oxide Synthase 3 (Nos3)Glu298asp Gene Variation In Breast Cancer Patients
CACINA CANAN,HOROZOĞLU CEM,erbaşoğlu öncü,TOPTAŞ BAHAR,YILDIZ YEMLİHA,ARİKAN SOYKAN,KÜÇÜCÜK SEDEN,YAYLIM İLHAN. International Journal of Genetic Science,
2017 - MEME KANSERLİ HASTALARDA ABCG2 G34A GENPOLİMORFİZMİNİN İNCELENMESİ
YILDIZ YEMLİHA,arıkan soykan,candan gonca,turan saime,YAYLIM İLHAN,ERGEN HAYRİYE ARZU. lectio scientific,
2017 - Mitochondrial DNA analysis of the domestic dogs in Turkey
ERKAN ITIR,DASTAN KADİR,KARADENİZ SEDAT TANJU,YILDIZ YEMLİHA,ALPSAR DİLEK,YÜKSELOĞLU EMEL HÜLYA. European Journal of Forensic Sciences,
2014 - Association between Laryngeal Squamous Cell Carcinoma and Polymorphisms in Tumor Necrosis Factor Related Apoptosis Induce Ligand TRAIL TRAIL Receptor and sTRAIL Levels
VERİM AYŞEGÜL,TURAN SAİME,FAROOQI AMMAD AHMAD,TİMİRCİ KAHRAMAN ÖZLEM,TEPE KARACA ÇİĞDEM,YILDIZ YEMLİHA,NAIBOĞLU BARIŞ,ÖZKAN NAZLI EZGİ,ERGEN HAYRİYE ARZU,AYDINOĞLU IŞITMAGİL GÜLBU,YAYLIM İLHAN. Asian Pacific Journal of Cancer Prevention,
2013 - Nitrik Oksit Sentaz 3 NOS3 Glu298Asp Gen Varyasyonunun Meme Kanserli Hastalarda İncelenmesi
CACINA CANAN,ARIKAN SOYKAN,YILDIZ YEMLİHA,TOPBAŞ BAHAR,TURAN SAİME,ÖZKAN NAZLI EZGİ,GURBET KORKMAZ,KÜÇÜCÜK NEZİHE SEDEN,YAYLIM İLHAN,İSBİR TURGAY. Deneysel Tıp Araştırma Enstitüsü Dergisi,
2013 - Bax promoter G 248 A polymorphism in a Turkish clinical breast cancer patients A case control study
YILDIZ YEMLİHA,YAYLIM İLHAN,ÖZKAN NAZLI EZGİ,ARIKAN SOYKAN,TURAN SAİME,KÜÇÜCÜK NEZİHE SEDEN,COŞKUNPINAR ENDER,İSBİR TURGAY. American Journal of Molecular Biology,
2012 - sTRAIL Serum Levels and TRAIL 1595 Genotypes Association with Progress and Prognosis of Colorectal Carcinoma
YAYLIM İLHAN,ÖZKAN NAZLI EZGİ,TURAN SAİME,KORKMAZ GURBET,YILDIZ YEMLİHA,CACINA CANAN,TOPBAŞ BAHAR,ARIKAN SOYKAN. Journal of Cancer Therapy,
2010 - Is there any correlation between TNF related apoptosis inducing ligand TRAIL genetic variants and breast cancer
YILDIZ YEMLİHA,YAYLIM İLHAN,ARIKAN SOYKAN,ERGEN HAYRİYE ARZU,KÜÇÜCÜK NEZİHE SEDEN,İSBİR TURGAY. Archives of Medical Science,
2010 - The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population
YAYLIM İLHAN,ARIKAN SOYKAN,YILDIZ YEMLİHA,CACINA CANAN,ERGEN HAYRİYE ARZU,TUNA GÜLAY,GÖRMÜŞ UZAY,ZEYBEK ŞAKİR ÜMİT,İSBİR TURGAY. ANTICANCER RESEARCH,
2009 - Breast cancer and cyclin d1 gene polymorphism in Turkish women
YAYLIM İLHAN,ERGEN HAYRİYE ARZU,GÖRMÜŞ UZAY,ARIKAN SOYKAN,KÜÇÜCÜK NEZİHE SEDEN,ŞAHİN ORHAN,YİĞİT NİLÜFER,YILDIZ YEMLİHA,İSBİR TURGAY. IN VIVO,